Skip to content
Seraph 100 – COVID-19 Innovation
Seraph 100 – An Innovative Approach to Treating Critically Ill Covid-19 Patients
ExThera Medical recently introduced the Seraph 100 Microbind Affinity Blood Filter (Seraph 100) – a treatment for COVID-19 with FDA Emergency Use Authorization. In January 2021, Resolute Public Affairs was engaged by Exthera to create a media effort to raise its national profile.
Resolute aggressively set out to tell its story and the media is taking note. The news of this groundbreaking innovation in the treatment of critically ill COVID-19 patients has been covered by Wall Street Journal, USA Today and local markets.